The donut hole was a gap in Medicare Part D prescription drug coverage that occurred between the initial stage and catastrophic stage of coverage. In 2025, new rules under the Inflation Reduction ...

It had various effects on Medicare, such as improving coverage and eliminating the drug coverage gap (also called the donut hole). More than 68 million people in the United States are enrolled in ...

In one of its last actions, the Biden administration released the next 15 drugs selected for Medicare negotiation and the blockbuster diabetes drug Ozempic will be among those bargained for this year.

Popular diabetes drugs such as Ozempic and Trulicity are among 25 drugs Medicare has spent the most on but hasn't yet selected for price negotiation, according to a report released Thursday.

According to CMS, close to 2.3 million seniors enrolled in Medicare are using Novo Nordisk’s semaglutide medications branded as Ozempic, Wegovy and Rybelsus. Between November 2023 and October ...

CMS listed Ozempic, Rybelsus and Wegovy — all forms of semaglutide — at the top of the list of drugs for which Medicare will the negotiate the price of in 2025. The list price for a one-month ...

Jan. 17, 2025 – Medicare will negotiate the prices of weight loss drugs Wegovy and Ozempic with drug companies, a move that could create big savings for seniors who take the drugs, the Biden ...

The move could mean savings for consumers. Weight loss drugs Ozempic and Wegovy have been added to the list of medications Medicare will be able to negotiate directly with drug manufacturers ...

Popular diabetes drugs such as Ozempic and Trulicity are among 25 drugs Medicare has spent the most on but hasn't yet selected for price negotiation, according to a report released Thursday. The ...

WASHINGTON -- Popular weight loss and diabetes drugs like Ozempic and Wegovy have been added to Medicare’s list of medications that will be negotiated directly between the government and drug ...